Skip to main content

Market Overview

HOOKIPA Pharma: Q4 Earnings Insights



Shares of HOOKIPA Pharma (NASDAQ:HOOK) remained unaffected after the company reported Q4 results.

Quarterly Results

Earnings per share decreased 15.00% over the past year to ($0.46), which beat the estimate of ($0.58).

Revenue of $5,163,000 higher by 42.70% from the same period last year, which beat the estimate of $4,260,000.


HOOKIPA Pharma hasn't issued any earnings guidance for the time being.

HOOKIPA Pharma hasn't issued any revenue guidance for the time being.

Details Of The Call

Date: Mar 18, 2021

Time: 08:30 AM

ET Webcast URL:


Company's 52-week high was at $13.68

Company's 52-week low was at $6.00

Price action over last quarter: Up 13.55%

Company Description

HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.


Related Articles (HOOK)

View Comments and Join the Discussion!

Posted-In: BZI-RecapsEarnings News

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at